|
A new approach that analyzes just a few drops of blood, is able to detect if diabetic patients have developed life-threatening vascular complications
The U.S. Food and Drug Administration (FDA) approved a new indication for Janssen Pharmaceutical’s Invokana (R) today. The new indication is to
High blood sugar levels can damage all parts of your body. In this post, we’ll guide you through all the parts of your body, head to toe that
Astra Zeneca announced promising results of a phase 3 trial of Farxiga, which showed to reduce the progression of kidney disease or renal death in
Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the
Renalytix AI, a company developing of artificial intelligence-enabled clinical diagnostics for kidney disease, announced that it has been granted
A new landmark clinical trial from Standford Medicine shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the
The U.S. Food and Drug Administration (FDA) has approved a label update for AstraZeneca’s FARXIGA® (dapagliflozin) and XIGDUO® XR
Vitamin B supplements have a protective effect on kidney function in children and adolescents with Type 1 diabetes, according to new research. The
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: